Malak Abedalthagafi Selected Research

Malak Abedalthagafi Research Topics

Disease

26	Neoplasms (Cancer) 06/2021 - 02/2010
11	Meningioma (Meningiomas) 09/2019 - 11/2014
5	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2015
4	Brain Neoplasms (Brain Tumor) 04/2021 - 10/2015
3	Turcot syndrome 09/2022 - 12/2018
3	Craniopharyngioma (Craniopharyngiomas) 01/2018 - 02/2016
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2015
2	COVID-19 01/2022 - 01/2021
2	Pituitary Neoplasms (Pituitary Adenoma) 06/2021 - 06/2016
2	Breast Neoplasms (Breast Cancer) 03/2021 - 01/2017
2	Astrocytoma (Pilocytic Astrocytoma) 09/2014 - 11/2013
1	Rhabdomyosarcoma 09/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Acoustic Neuroma (Acoustic Neurinoma) 12/2020
1	Neurilemmoma (Schwannoma) 12/2020
1	Carcinogenesis 09/2019
1	Choroid Plexus Carcinoma 01/2018
1	Adenoma (Adenomas) 01/2017
1	Oxyphilic Adenoma (Oncocytoma) 06/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2015
1	Hemangioblastoma 12/2014
1	Oligodendroglioma 09/2014
1	alpha-Thalassemia 11/2013
1	Intellectual Disability (Idiocy) 11/2013
1	Lymphedema (Milroy Disease) 02/2010
1	Hypoxia (Hypoxemia) 02/2010
1	Hemangiosarcoma (Angiosarcoma) 02/2010

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 06/2021 - 02/2010
4	Immune Checkpoint InhibitorsIBA 09/2022 - 10/2018
4	Biological ProductsIBA 01/2018 - 09/2014
3	B7-H1 AntigenIBA 06/2021 - 03/2015
3	Hormones (Hormone)IBA 01/2018 - 06/2016
2	LigandsIBA 06/2021 - 12/2020
2	MutS ProteinsIBA 06/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2019
2	Temozolomide (Temodar)FDA LinkGeneric 12/2018 - 01/2018
2	VaccinesIBA 10/2018 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2010
2	Messenger RNA (mRNA)IBA 01/2017 - 03/2015
2	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 12/2014
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2015 - 11/2013
1	Programmed Cell Death 1 ReceptorIBA 09/2022
1	AnticoagulantsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	OX40 ReceptorsIBA 06/2021
1	AntibodiesIBA 01/2021
1	Alcian BlueIBA 01/2021
1	larotrectinibIBA 01/2020
1	MutL Protein Homolog 1IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	NivolumabIBA 12/2018
1	Thyroglobulin FDA Link 10/2018
1	Prealbumin (Transthyretin)IBA 10/2018
1	Chromogranin AIBA 10/2018
1	Peptides (Polypeptides)IBA 01/2018
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018
1	Cell Surface ReceptorsIBA 01/2018
1	LeptinIBA 01/2018
1	Leptin ReceptorsIBA 01/2018
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	UbiquitinIBA 01/2017
1	Growth Hormone (Somatotropin)IBA 01/2017
1	trametinibIBA 02/2016
1	dabrafenibIBA 02/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	epidermal growth factor receptor VIIIIBA 10/2015
1	ParaffinIBA 10/2015
1	Formaldehyde (Formol)FDA Link 10/2015
1	MethyltransferasesIBA 09/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2013
1	X-linked Nuclear ProteinIBA 11/2013
1	GoldIBA 02/2010
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010
1	Thorium Dioxide (Thorotrast)IBA 02/2010

Therapy/Procedure

16	Therapeutics 09/2022 - 01/2015
4	Radiotherapy 12/2018 - 09/2012
3	Immunotherapy 01/2021 - 01/2018
3	Drug Therapy (Chemotherapy) 12/2018 - 01/2016
2	Precision Medicine 01/2016 - 01/2016
1	Respiratory Therapy (Therapy, Respiratory) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Immunomodulation 12/2020
1	Operative Surgical Procedures 01/2020
1	Neurosurgical Procedures 01/2020
1	Craniospinal Irradiation 09/2015
1	Craniotomy 09/2015
1	Salvage Therapy 11/2014